These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 1903594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model.
    Doody KJ, Dunn RC, Buttram VC.
    Fertil Steril; 1989 Mar; 51(3):509-12. PubMed ID: 2493405
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The ability of recombinant tissue plasminogen activator to inhibit post-radical pelvic surgery adhesions in the dog model.
    Montz FJ, Fowler JM, Wolff AJ, Lacey SM, Mohler M.
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1539-42. PubMed ID: 1957891
    [Abstract] [Full Text] [Related]

  • 7. Tissue-type plasminogen activator and adhesion prevention.
    Dunn RC.
    Prog Clin Biol Res; 1993 Nov; 381():213-20. PubMed ID: 8316565
    [No Abstract] [Full Text] [Related]

  • 8. Calcium channel blockade prevents postsurgical reformation of adnexal adhesions in rabbits.
    Steinleitner A, Kazensky C, Lambert H.
    Obstet Gynecol; 1989 Nov; 74(5):796-8. PubMed ID: 2812657
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator.
    Menzies D, Ellis H.
    J R Soc Med; 1989 Sep; 82(9):534-5. PubMed ID: 2507782
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator.
    Orita H, Fukasawa M, Girgis W, diZerega GS.
    Int J Fertil; 1991 Sep; 36(3):172-7. PubMed ID: 1678373
    [Abstract] [Full Text] [Related]

  • 14. A randomised controlled trial on melatonin and rosiglitazone for prevention of adhesion formation in a rat uterine horn model.
    Aksakal O, Yilmaz B, Gungor T, Sirvan L, Sut N, Inan I, Kalyoncu S, Mollamahmutoglu L.
    Arch Gynecol Obstet; 2010 Jul; 282(1):55-61. PubMed ID: 19834723
    [Abstract] [Full Text] [Related]

  • 15. Prevention of postoperative adhesions by tissue-type plasminogen activator (t-PA) in the rabbit.
    Dörr PJ, Vemer HM, Brommer EJ, Willemsen WN, Veldhuizen RW, Rolland R.
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):287-91. PubMed ID: 2121563
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the effects of gonadotropin-releasing hormone antagonist (GnRH-ant) and agonist (GnRH-a) in the prevention of postoperative adhesion formation in a rat model with immunohistochemical analysis.
    Tamay AG, Guvenal T, Micili SC, Yildirim Y, Ozogul C, Koyuncu FM, Koltan SO.
    Fertil Steril; 2011 Nov; 96(5):1230-3. PubMed ID: 21963228
    [Abstract] [Full Text] [Related]

  • 17. Experimental adhesion prophylaxis with recombinant tissue plasminogen activator.
    Vipond MN, Whawell SA, Scott-Coombes DM, Thompson JN, Dudley HA.
    Ann R Coll Surg Engl; 1994 Nov; 76(6):412-5. PubMed ID: 7702327
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.